A method for aldehyde-modified chicken erythrocytes and extending their preservation time

By adding a receptor protectant before aldehyde-treated chicken erythrocytes and performing graded aldehyde treatment, the problems of short preservation time and unstable result interpretation of aldehyde-treated chicken erythrocytes were solved, achieving long-term stable preservation and efficient detection.

CN123107923APending Publication Date: 2026-11-17SICHUAN HUAPAI BIO PHARMA
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202611474425.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-09-21
Publication Date
2026-11-17

AI Technical Summary

Technical Problem

Existing aldehyde-modified chicken erythrocytes have a short preservation time, and the cross-linking process can mask or damage the sialic acid receptors on the membrane surface, leading to a decrease in HA/HI titer. Furthermore, they are prone to hemolysis when shaken, which cannot meet the requirements for long-term stable preservation and rapid result determination.

Method used

Before aldehyde-treated chicken erythrocytes, a receptor protectant was added for pretreatment, followed by graded aldehyde treatment. By increasing the concentration of the aldehyde reagent in stages, the remaining aldehyde groups were blocked by glycine, thus forming stable aldehyde-treated chicken erythrocytes.

Benefits of technology

It enables the stable preservation of aldehyde-modified chicken erythrocytes at 2–8℃ for at least 12 months, and repeated shaking does not affect the result interpretation. The HA/HI titer is equivalent to that of fresh chicken erythrocytes, and it is suitable for the detection of various avian virus antigens and antibodies.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN123107923A_ABST
    Figure CN123107923A_ABST
Patent Text Reader

Abstract

This invention belongs to the field of veterinary diagnostic biological products and in vitro diagnostic reagents, and discloses an aldehyde-modified chicken erythrocyte and a method for extending its storage time. The aldehyde-modified chicken erythrocyte prepared by this invention shows a concordance rate of ≥85% with fresh chicken erythrocytes in HA and HI tests, solving the problem of limited chicken source for freshly prepared 1% chicken erythrocyte SPF and the need for result determination within minutes when the control well is established. Furthermore, it can be stored at 2-8℃ for at least 12 months without affecting result determination even with repeated shaking, solving the problem of easy hemolysis when shaking and storage at 4℃ for no more than 7 days for freshly prepared 1% chicken erythrocytes.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention belongs to the field of veterinary diagnostic biological products and in vitro diagnostic reagents, specifically relating to an aldehyde-treated chicken erythrocyte and a method for extending its preservation time. Background Technology

[0002] Chicken erythrocytes are the gold standard indicator cells for avian serological detection (such as avian influenza virus, Newcastle disease virus, egg drop syndrome virus, and infectious bronchitis virus). The principle is that hemagglutinin (HA) on the surface of the virus directly binds to sialic acid (Sia) receptors on the chicken erythrocyte membrane, causing agglutination. Current serological detection methods, such as the hemagglutination assay (HA) and hemagglutination inhibition assay (HI), mostly use freshly prepared 1% chicken erythrocytes. However, due to limitations in SPF chicken sources, some testing sites cannot prepare fresh 1% chicken erythrocytes. Furthermore, freshly prepared 1% chicken erythrocytes are susceptible to hemolysis when shaken, cannot be stored at 4°C for more than 7 days, and the results of control wells must be interpreted within minutes, affecting the accuracy of test results.

[0003] To address the issues of limited SPF chicken supply and short shelf life, a common solution is to use aldehyde-modified chicken erythrocytes. The principle behind aldehyde-modified erythrocytes is to confer hemolysis resistance, freeze-thaw resistance, and long-term storage stability through cross-linking of membrane proteins, giving the erythrocytes a strong ability to adsorb protein antigens or antibodies. However, during the aldehyde modification process, cross-linking can mask, modify, or even damage the sialic acid receptors on the membrane surface, resulting in decreased HA / HI titers and incompatibility with fresh chicken cells. Furthermore, most commercially available 1%-20% aldehyde-modified chicken erythrocytes currently have a short shelf life. For example, patent CN116941603A states that "after repeated studies, the storage period at 2-8℃ is only about 30 days, which cannot achieve a shelf life of 1-7 years." Therefore, extending the storage time of aldehyde-modified chicken erythrocytes is crucial. Summary of the Invention

[0004] To address the aforementioned shortcomings of existing technologies, this invention provides a method for aldehyde-treated chicken erythrocytes and extending their preservation time. This invention pre-treats the chicken erythrocytes with a receptor protectant before aldehyde treatment, followed by graded aldehyde treatment, ensuring that the aldehyde-treated chicken erythrocytes simultaneously meet the following requirements: ① HA / HI titer is equivalent to that of fresh chicken erythrocytes (≥85%); ② They can be stably stored at 2–8℃ for at least 12 months without affecting result interpretation after repeated shaking; ③ Their sedimentation morphology is similar to that of fresh cells, and their HA / HI interpretation is consistent; ④ They can detect antigens and antibodies against various avian viruses.

[0005] To achieve the above objectives, the technical solution adopted by the present invention to solve its technical problem is as follows: The purpose of this invention is to provide a method for extending the preservation time of aldehyde-treated chicken erythrocytes, which includes the following steps: (1) Add chicken red blood cells to a receptor protectant solution to a final concentration of 5-10%, and incubate at 2-8°C for 30-60 min to obtain a red blood cell suspension; the receptor protectant solution includes polysialic acid at a mass concentration of 0.01-1.5% (w / v) and galactose blocking solution at a mass concentration of 0.05-0.1%; (2) The red blood cell suspension is subjected to graded aldehyde treatment. The volume concentration of the aldehyde reagent in the red blood cell suspension is increased from 0.001~0.005% to 0.1~0.5% (v / v) through graded aldehyde treatment. (3) After aldehyde conversion is completed, the reaction is terminated and the remaining aldehyde groups are blocked. After incubation at room temperature for 30-60 minutes, the cells are centrifuged to obtain aldehyde-converted chicken red blood cells.

[0006] Furthermore, in step (1), the mass concentration of chicken erythrocytes in the receptor protectant solution is 10%.

[0007] Furthermore, the receptor protectant solution comprises polysialic acid at a mass concentration of 0.01–1.0% and galactose blocking solution at a mass concentration of 0.05–0.1%.

[0008] Furthermore, the graded aldehyde process in step (2) is as follows: S1. While stirring, add an aldehyde reagent to the red blood cell suspension to achieve a volume concentration of 0.002~0.005% in the red blood cell suspension, and stir at 2~8℃ for 10~30 min. After S2 and S1 aldehydes are completed, aldehyde reagent is added to the system to make its volume concentration in the red blood cell suspension reach 0.02~0.05%, and then stirred at 2~8℃ for 1~4h. After S3 and S2 aldehydes are completed, aldehyde reagent is added to the system to achieve a volume concentration of 0.2-0.5% in the red blood cell suspension, and then the mixture is stirred at 2-8°C for 12-14 hours.

[0009] Furthermore, the aldehyde reagent is formaldehyde, genipin, microbial transglutaminase, or HRP / H2O2.

[0010] Furthermore, polysialic acid is a commercially available product, and industrially it is often obtained by fermentation of Neisseria meningitidis B or Escherichia coli K1.

[0011] Further, in step (3), glycine at a concentration of 0.1~1M is used to terminate the reaction and block the remaining aldehyde groups.

[0012] Another object of the present invention is to provide an aldehyde-modified chicken erythrocyte prepared by the above method.

[0013] The beneficial effects of this invention are: 1. Conventional high-concentration aldehyde crosslinking involves a single step, resulting in high crosslink density and an "all or nothing" fixation characteristic. This leads to dense crosslinking and masking of surface sialic acid receptors, causing a decrease in HA / HI titers. This invention employs staged aldehyde conversion. First, an ultra-low concentration is used to fix the membrane backbone, preventing hemolysis from washing and freeze-thaw cycles. At this stage, the receptor protectant has already occupied / covered the receptor sites. In the second stage, the protectant is added to reach the target concentration to complete stabilization while it is still in place. This staged conversion staggers the "receptor protection window" and "stable crosslinking" in both time and concentration, thereby maximizing receptor activity while achieving hemolysis / oscillation-resistant stability.

[0014] 2. The aldehyde-modified chicken erythrocytes prepared by this invention showed a ≥85% concordance rate with fresh chicken erythrocytes during HA and HI tests, solving the problem that the source of freshly prepared 1% chicken erythrocyte SPF is limited and the result determination of the control well must be carried out within a few minutes.

[0015] 3. The aldehyde-modified chicken erythrocytes prepared by this invention can be stored at 2-8℃ for at least 12 months and repeated shaking does not affect the result determination. This solves the problem that freshly prepared 1% chicken erythrocytes are prone to hemolysis when shaken and cannot be stored at 4℃ for more than 7 days during use. Attached Figure Description

[0016] Figure 1 The graph shows the comparison results of 1% fresh chicken red blood cell suspension and 1% aldehyde-modified chicken red blood cell suspension prepared in Example 1 at different times. Detailed Implementation

[0017] The specific embodiments of the present invention are described below to enable those skilled in the art to understand the present invention. However, it should be understood that the present invention is not limited to the scope of the specific embodiments. For those skilled in the art, various changes are obvious as long as they are within the spirit and scope of the present invention as defined and determined by the appended claims. All inventions utilizing the concept of the present invention are protected.

[0018] Example 1: A method for preparing an aldehyde-modified chicken erythrocyte suspension, comprising the following steps: 1. Red blood cell pretreatment Collect SPF chicken blood in centrifuge tubes containing Alderman's solution, incubate at 4°C for 4-6 hours, centrifuge at 1500-2000 rpm for 10 minutes, discard the supernatant, wash 2-3 times with PBS (pH 7.2), and adjust the hematocrit (PCV). 2. Receptor protectant pretreatment PCV was resuspended in PBS (pH 7.2) containing a receptor protectant to a concentration of 10%, and incubated at 2–8°C for 30 min–1 h. The receptor protectant consisted of: ① 0.01–1.0 % (w / v, g / mL) polysialic acid (PSA) derived from Neisseria meningitidis; ② 0.1% galactose blocking solution (a 0.1 wt% galactose solution used as a blocking agent). These reagents formed a protective glycan network on the PCV membrane surface through gentle physical adsorption, thereby achieving receptor protection.

[0019] 3. Graded aldehyde treatment Place a 10% red blood cell suspension pretreated with receptor protectant on a magnetic stirrer, and add 0.002%~0.005% (v / v) glutaraldehyde while stirring. Stir at 2~8℃ for 10~30 min. Add to a final concentration of 0.02%~0.05% (v / v) glutaraldehyde and continue stirring at 2~8℃ for 1~4 h. Add to a final concentration of 0.2%~0.5% (v / v) glutaraldehyde and continue stirring at 2~8℃ for 12~14 h.

[0020] 4. Termination and residue blocking Add 0.1-1M glycine to the aldehyde-treated chicken red blood cell suspension to terminate the reaction and block the remaining aldehyde groups. After incubating at room temperature for 30 min to 1 h, centrifuge at 1500-2000 rpm for 10 min, discard the supernatant, and wash 2-3 times with PBS (pH 7.2).

[0021] 5. Volume adjustment and preservation Adjust the concentration of aldehyde-treated red blood cells to 1%–10%. After adjustment with PBS (pH 7.2), the cells can be stored at 2–8°C for one year.

[0022] Example 2 Blood Coagulation (HA) Test Procedure The experiment was conducted using 96-well V-type microplates with a total reaction volume of 50 μl. The procedure was performed according to Table 1. Hemagglutinin was diluted with PBS to different concentrations, and then 1% chicken erythrocyte suspension (1% fresh chicken erythrocyte suspension or 1% aldehyde-modified chicken erythrocyte suspension) was added. The mixture was immediately shaken on a microplate shaker and incubated at room temperature for 20-40 minutes. The result was determined when the erythrocytes in the control wells showed a distinct button-like appearance.

[0023] 2. Result Determination 1% fresh chicken red blood cell suspension: The highest dilution that causes complete agglutination of red blood cells is used as the endpoint; 1% aldehyde-treated chicken red blood cell suspension: The highest dilution that causes 50% agglutination of red blood cells is used as the endpoint.

[0024] Table 1. Blood coagulation test procedure (unit: μl)

[0025] Note: "-" indicates no result.

[0026] Example 3: Blood Coagulation Inhibition (HI) Test Procedure 1. Preparation of hemagglutinin working solution 1.1 Determination of hemagglutinin agglutination titer The experiment was conducted using 96-well V-type microplates with a total reaction volume of 75 μl. The procedure was performed according to Table 2. Hemagglutinin was diluted with PBS to different concentrations, and an equal volume of PBS as the serum volume used in the inhibition test was added. Then, 1% chicken erythrocyte suspension (1% fresh chicken erythrocyte suspension or 1% aldehyde-modified chicken erythrocyte suspension) was added, and the mixture was immediately shaken on a microplate shaker. The plate was incubated at room temperature for 20–40 minutes. The result was determined when the erythrocytes in the control wells showed a distinct button-like appearance.

[0027] 1% fresh chicken red blood cell suspension: The highest dilution that causes complete agglutination of red blood cells is used as the endpoint; 1% aldehyde-treated chicken red blood cell suspension: The highest dilution that causes 50% agglutination of red blood cells is used as the endpoint.

[0028] Table 2. Determination of hemagglutinin agglutination titer (unit: μl)

[0029] Note: "-" indicates no result.

[0030] 1.2 Preparation and testing of hemagglutinin working solution 1.2.1 Preparation of 4HAU hemagglutinin If the hemagglutinin titer is 1:1024 (for example), 4 hemagglutination units (4 HAU) = 1024 / 4 = 256 (i.e., 1:256). Take 9.0 ml of PBS, add 1.0 ml of hemagglutinin to make a 1:10 dilution, and add 1.0 ml of the 1:10 dilution to 24.6 ml of PBS to make the final concentration 1:256.

[0031] 1.2.2 Inspection To check the accuracy of the erythrocyte agglutination titer of 4 HAU, the prepared 1:256 dilution solution should be added in 1.0 ml increments to 1.0 ml, 2.0 ml, 3.0 ml, 4.0 ml, 5.0 ml, and 6.0 ml of PBS, respectively, to achieve final dilutions of 1:2, 1:3, 1:4, 1:5, 1:6, and 1:7. Then, take 25 μl from each dilution, add 25 μl of PBS, and then add 25 μl of 1% chicken erythrocyte suspension (1% fresh chicken erythrocyte suspension or 1% aldehyde-modified chicken erythrocyte suspension). Immediately mix on a microplate shaker and allow to react at room temperature. The result is determined when the erythrocytes in the control wells show a distinct button-like appearance. For 1% fresh chicken erythrocyte suspension: the highest dilution that achieves complete erythrocyte agglutination is used as the endpoint; for 1% aldehyde-modified chicken erythrocyte suspension: the highest dilution that achieves 50% erythrocyte agglutination is used as the endpoint.

[0032] If the prepared antigen is also 4 HAU, a 1:4 dilution will give the agglutination endpoint; if 4 HAU is higher than 4 units, a 1:5 or 1:6 dilution may be the endpoint; if it is lower, a 1:2 or 1:3 dilution may be the endpoint. The hemagglutinin dilution should be adjusted appropriately according to the test results to ensure that the working solution is indeed 4 HAU.

[0033] 2. Hemagglutination inhibition (HI) test Serum was serially diluted 2-fold with PBS according to Table 3. Hemagglutinin solution containing 4 HAU was added, and PBS and hemagglutinin controls were set up. After thorough mixing, the mixture was kept at room temperature for at least 20 minutes. Then, 1% chicken red blood cell suspension (1% fresh chicken red blood cell suspension or 1% aldehyde-modified chicken red blood cell suspension) was added. The mixture was immediately shaken on a microplate shaker and kept at room temperature for 20 to 40 minutes. The results were determined when the red blood cells in the control wells showed a distinct button-like appearance.

[0034] 1% fresh chicken red blood cell suspension: The highest hemagglutination dilution that completely inhibits red blood cell aggregation is used as the endpoint; 1% aldehyde-treated chicken red blood cell suspension: The highest hemagglutination dilution that completely inhibits 50% agglutination of red blood cells is used as the endpoint.

[0035] Table 3. Procedure for Hemagglutination Inhibition Test (Unit: μl)

[0036] Note: "-" indicates no result.

[0037] Example 4: Comparison of fresh chicken red blood cell suspension and aldehyde-modified chicken red blood cell suspension 1. Preparation of 1% fresh chicken red blood cell suspension Collect SPF chicken blood in centrifuge tubes containing Alderman's solution, let stand at 4°C for 4-6 hours, centrifuge at 1500-2000 rpm for 10 minutes, discard the supernatant, wash 2-3 times with PBS (pH 7.2) to prepare a 1% fresh chicken red blood cell suspension.

[0038] 2. Operation The 10% aldehyde-treated chicken red blood cells from Example 1 were diluted with PBS (pH 7.2) to form a 1% aldehyde-treated chicken red blood cell suspension.

[0039] Using 1% fresh chicken erythrocyte suspension and 1% aldehyde-modified chicken erythrocyte suspension (prepared in Example 1), the HA antigen titer of the hemagglutination inhibition test antigen of avian influenza virus H7 subtype (H7-Re4 strain) (purchased from Harveco, 2024005) was determined according to Example 2, and the HI antibody titer of positive serum of avian influenza virus H7 subtype (H7-Re4 strain) (purchased from Harveco, 2024001) was determined according to Example 3.

[0040] 3. Results 3.1 Hemagglutination test (HA) Both 1% fresh chicken red blood cells and 1% aldehyde-treated chicken red blood cells were established as control wells after 20 minutes, at which point the antigen results were consistent, both showing 2. 8 (Table 4).

[0041] As the reaction time increases ( Figure 1 a) In the control wells with 1% fresh chicken erythrocytes, the reaction was deemed invalid after 40 minutes. Furthermore, the rate of sag in the reaction wells at 40 minutes differed significantly from that at 20 minutes. The first four wells, which had a uniform, diffuse agglomeration state at 20 minutes, became exhibited red deposits that did not sag. These red deposits were similar to those in the control wells, making it impossible to distinguish between erythrocyte deposition and agglomeration, thus hindering result interpretation. In contrast, the control wells with 1% aldehyde-treated chicken erythrocytes were unaffected. Deposits appeared in the first two wells around 1 hour, but these deposits differed significantly from those in the control wells and had almost no impact on result interpretation. The HA titer remained at 2 from 20 minutes to 1 hour. 8 .

[0042] Table 4. Comparison of fresh chicken red blood cell suspension and aldehyde-modified chicken red blood cell suspension in hemagglutination test (HA).

[0043] Note: "-" indicates no result.

[0044] 3.2 Hemagglutination inhibition test (HI) Both 1% fresh chicken erythrocytes and 1% aldehyde-treated chicken erythrocytes were effective in the control wells after 40 minutes. At this point, the results for positive serum were consistent, both showing 2. 10(Table 5). As the reaction time increases ( Figure 1 (b) Red blood cell deposition continued to occur in the reaction wells containing 1% fresh chicken red blood cells, and the HI titers at 45 min and 1 h were both greater than 2. 12 HI titer at 40 min (2 10 A significant difference was observed. The HI titer of 1% aldehyde-treated chicken erythrocytes in the reaction wells was essentially the same at 45 min and 40 min, at 2. 10 Red blood cell deposition continued after 1 hour, with an HI titer of 2. 11 .

[0045] Table 5 Comparison of fresh chicken red blood cell suspension and aldehyde-treated chicken red blood cell suspension in the hemagglutination inhibition test (HI).

[0046] Note: "-" indicates no result.

[0047] A comparison of fresh chicken erythrocyte suspension and aldehyde-modified chicken erythrocyte suspension in hemagglutination and hemagglutination inhibition tests showed that the results of the two were basically consistent within 40 minutes. However, as the detection time was extended, the aldehyde-modified chicken erythrocyte suspension was more stable in terms of control establishment and detection results, which solved the problem that the result determination needed to be carried out within a few minutes in the actual detection process.

[0048] Example 5: Comparison of conventional aldehyde-modified chicken erythrocyte suspension with that of Example 1. 1. Preparation of conventional aldehyde-treated chicken erythrocyte suspension Collect SPF chicken blood in centrifuge tubes containing Alderman's solution, incubate at 4°C for 4-6 hours, centrifuge at 1500-2000 rpm for 10 min, discard the supernatant, and wash 2-3 times with PBS (pH 7.2) to obtain a 10% chicken red blood cell suspension. Place the 10% chicken red blood cell suspension on a magnetic stirrer, and while stirring, add 0.2%-0.5% (v / v) glutaraldehyde, and continue stirring at 2-8°C for 15-18 hours. Add 0.1-1M glycine to the aldehyde-treated chicken red blood cell suspension to terminate the reaction and block the remaining aldehyde groups. Incubate at room temperature for 30 min-1 hour, centrifuge at 1500-2000 rpm for 10 min, discard the supernatant, and wash 2-3 times with PBS (pH 7.2). Then adjust the concentration of the aldehyde-treated red blood cells to 1%-10%.

[0049] 2. Operation The 10% aldehyde-treated chicken erythrocytes from Example 1 were diluted with PBS (pH 7.2) to prepare a 1% aldehyde-treated chicken erythrocyte suspension. Using both the 1% conventional aldehyde-treated chicken erythrocyte suspension and the 1% aldehyde-treated chicken erythrocyte suspension prepared in Example 1, the HA antigen titer of the hemagglutination inhibition test antigen of avian influenza virus H7 subtype (H7-Re4 strain) (purchased from Harveco, 2024005) was determined according to Example 2. The HI antibody titer of avian influenza virus H7 subtype (H7-Re4 strain) positive serum (purchased from Harveco, 2024001) was determined according to Example 3.

[0050] 3. Results The results of the HA and HI tests (Table 6) showed that the interpretation deviation between 1% conventional aldehyde-modified chicken red blood cell suspension and 1% aldehyde-modified chicken red blood cell suspension of Example 1 was 1-2 titers.

[0051] Table 6. Comparison of conventional aldehyde-treated chicken erythrocytes and aldehyde-treated chicken erythrocytes from Example 1

[0052] Example 6 HA and HI tests on aldehyde-treated chicken erythrocytes prepared in Example 1 1. Hemagglutination test (HA) The 10% aldehyde-modified chicken erythrocytes from Example 1 were diluted with PBS (pH 7.2) to prepare a 1% aldehyde-modified chicken erythrocyte suspension. Following Example 2, the hemagglutination inhibition test antigens for avian influenza virus H5 subtype (H5-Re15 and H5-Re16 strains) and avian influenza virus H7 subtype (H7-Re5 and H7-Re6 strains) were measured using both 1% fresh chicken erythrocyte suspensions and 1% aldehyde-modified chicken erythrocyte suspensions. All four antigens were purchased from Harveco, 2025004. The avian influenza virus H9 subtype antigen (HN106 strain, G strain and WD strain), Newcastle disease virus antigen (aSG10 strain and LaSota strain), avian infectious bronchitis virus antigen (M41 strain), and egg drop syndrome antigen (HSH23 strain) were all prepared in-house and their antigen titers have been determined.

[0053] The results (Table 7) showed that 10 / 11 (90.91%) of the HA titers measured using 1% aldehyde-treated chicken erythrocytes were completely consistent with those measured using 1% fresh chicken erythrocytes, while 1 / 11 (9.09%) had a titer difference of one titer. The HA titer was ≥90% equivalent to that of fresh erythrocytes.

[0054] Table 7 Application of 1% aldehyde-treated chicken erythrocytes in hemagglutination assay (HA)

[0055] 2. Hemagglutination inhibition test (HI) The 10% aldehyde-treated chicken erythrocytes from Example 1 were diluted with PBS (pH 7.2) to prepare a 1% aldehyde-treated chicken erythrocyte suspension. Positive sera for avian influenza virus H5 subtype (H5-Re15 and H5-Re16 strains) and avian influenza virus H7 subtype (H7-Re5 and H7-Re6 strains) were determined according to Example 3. All four positive sera were purchased from Harveco, 2025004. Positive sera for avian influenza virus H9 subtype (G strain), Newcastle disease virus (La Sota strain), avian infectious bronchitis virus (M41 strain), and egg drop syndrome antigen (HSH23 strain) were prepared in-house and their antibody HI titers have been determined.

[0056] The results (Table 8) showed that 7 / 8 (87.5%) of the HI titers measured using 1% aldehyde-treated chicken erythrocytes were completely consistent with those measured using 1% fresh chicken erythrocytes, while 1 / 8 (12.5%) showed a difference of 2 titers. The HI titer was ≥85% equivalent to that measured using 1% fresh chicken erythrocytes.

[0057] Table 8. Application of 1% aldehyde-treated chicken erythrocytes in the hemagglutination inhibition (HI) test.

[0058] Example 7: Preservation period test of aldehyde-treated chicken erythrocytes 1. Operation The 10% aldehyde-treated chicken erythrocytes (20250510) from Example 1 were diluted with PBS (pH 7.2) to prepare a 1% aldehyde-treated chicken erythrocyte suspension. The HA antigen titer of the Newcastle disease live vaccine (La Sota strain) (Huapai Biotechnology (Group) Co., Ltd., 2025001) was determined according to Example 2. The HI antibody titer of Newcastle disease virus-positive serum was determined according to Example 3.

[0059] 2. Preserve the test results The results of the HA and HI tests (Table 9) show that, when the same bottle of 10% aldehyde-modified chicken erythrocytes was stored at 2–8°C for 12 months, the titers of the antigens and antibodies tested after 12 shakes to prepare a 1% aldehyde-modified chicken erythrocyte suspension did not fluctuate by more than one titer. Therefore, 10% aldehyde-modified erythrocytes can be stored at 2–8°C for 12 months, and multiple shakes do not affect the results.

[0060] Table 9. Preservation period test of aldehyde-treated chicken erythrocytes

[0061] Finally, it should be noted that the above specific embodiments are only used to illustrate the technical solutions of the present invention and not to limit it. Although the present invention has been described in detail with reference to examples, those skilled in the art should understand that modifications or equivalent substitutions can be made to the technical solutions of the present invention without departing from the spirit and scope of the technical solutions of the present invention, and all such modifications and substitutions should be covered within the scope of the claims of the present invention.

Claims

1. A method for prolonging the preservation time of aldehyde-treated chicken erythrocytes, characterized in that, Includes the following steps: (1) Add chicken red blood cells to the receptor protectant solution to a final concentration of 5-10%, and incubate at 2-8°C for 30-60 min to obtain a red blood cell suspension; The receptor protectant solution comprises polysialic acid at a mass concentration of 0.01-1.5% and galactose blocking solution at a mass concentration of 0.05-0.1%. (2) The red blood cell suspension was subjected to graded aldehyde treatment, and the volume concentration of the aldehyde reagent in the red blood cell suspension was increased from 0.001~0.005% to 0.1~0.5% through graded aldehyde treatment. (3) After aldehyde conversion is completed, the reaction is terminated and the remaining aldehyde groups are blocked. After incubation at room temperature for 30-60 minutes, the cells are centrifuged to obtain aldehyde-converted chicken red blood cells.

2. The method according to claim 1, characterized in that, In step (1), the mass concentration of chicken erythrocytes in the receptor protectant solution is 10%.

3. The method according to claim 1 or 2, characterized in that, The receptor protectant solution comprises polysialic acid at a mass concentration of 0.01–1.0% and galactose blocking solution at a mass concentration of 0.05–0.1%.

4. The method according to claim 1, characterized in that, The graded aldehyde process in step (2) is as follows: S1. While stirring, add an aldehyde reagent to the red blood cell suspension to achieve a volume concentration of 0.002~0.005% in the red blood cell suspension, and stir at 2~8℃ for 10~30 min. After S2 and S1 aldehydes are completed, aldehyde reagent is added to the system to make its volume concentration in the red blood cell suspension reach 0.02~0.05%, and then stirred at 2~8℃ for 1~4h. After S3 and S2 aldehydes are completed, aldehyde reagent is added to the system to achieve a volume concentration of 0.2-0.5% in the red blood cell suspension, and then the mixture is stirred at 2-8°C for 12-14 hours.

5. The method according to claim 4, characterized in that, The aldehyde reagent is formaldehyde, genipin, microbial transglutaminase, or HRP / H2O2.

6. The method according to claim 1, characterized in that, Polysialic acid is obtained by fermentation of Neisseria meningitidis B or Escherichia coli K1.

7. The method according to claim 1, characterized in that, In step (3), glycine at a concentration of 0.1~1M is used to terminate the reaction and block the remaining aldehyde groups.

8. An aldehyde-modified chicken erythrocyte, characterized in that, It is prepared by the method described in any one of claims 1 to 7.